https://www.avient.com/sites/default/files/2024-11/Phil Clark Bio - 2024.pdf
Avient Corporation • 33587 Walker Road • Avon Lake, Ohio 44012 • 440.930.1000 •
www.avient.com
http://www.avient.com/
https://www.avient.com/sites/default/files/2025-02/MAXXAM Electronic Card Holder Application Snapshot.pdf
All Rights Reserved
https://www.avient.com/products/engineered-polymer-formulations/flame-retardant-formulations/maxxam-fr-flame-retardant-formulations-and-maxxam-nhfr-non-halogen-flame-retardant-formulations
Appliance Manufacturer
https://www.avient.com/sites/default/files/2025-02/MAXXAM Busbar Carrier EV Battery Application Snapshot.pdf
All Rights Reserved
https://www.avient.com/products/engineered-polymer-formulations/flame-retardant-formulations/maxxam-fr-flame-retardant-formulations-and-maxxam-nhfr-non-halogen-flame-retardant-formulations
Automotive OEM
https://www.avient.com/sites/default/files/2025-03/ECCOH XL Cable Insulation Case Study Snapshot.pdf
All Rights Reserved
https://www.avient.com/products/engineered-polymer-formulations/sustainable-formulations/eccoh-xl-cross-linkable-solutions
Power cable producer
https://www.avient.com/sites/default/files/2022-03/CESA Block Product Selector Guide.pdf
CESA BLOCK – STANDARD OFFERINGS
POLYMER FAMILY MATERIAL PRODUCT NAME DOSAGE
Polyolefin PEA0820045 CESA Block PEA0820045 1–5%
Polypropylene PPA0820056 CESA Block PPA0820056 1–5%
Polyamide ABA0820022 CESA Block ABA0820022 2–6%
Polyester NBA0820024 CESA Block NBA0820024 1–5%
Styrenic SLA0820010 CESA Block SLA0820010 1–5%
TPU RUA0820028 CESA Block RUA0820028 1–5%
CESA Block additives can be used in combination with other CESA masterbatches, and formulations can be customized for most applications.
https://www.avient.com/sites/default/files/2024-12/Certificate ISO 22000_Tangerang.pdf
View PDF
The SQS herewith attests that the organisation named below has a management system that meets the requirements of
the normative base mentioned.
7
0
0
1
_1
/A
p
ri
l
2
0
2
2
/V
er
si
o
n
2
.0
Certificate
P.T.
Kalisabi No. 1,
Kec.
Cibodas
15138 Kecamatan Cibodas, Tangerang
Indonesia
Scope
Category I
Production of customer specific Masterbatches for
Food packaging materials on the dedicated extrusion
lines
Normative base
ISO 22000:2018 Food Safety Management Systems - Requirements
for any organization in the food chain
Reg. no. 46391
Page 1 of 1
Validity 25. 02. 2024 – 24. 02. 2027
Issue 25. 02. 2024
A.Grisard, President SQS F.
https://www.avient.com/sites/default/files/2022-06/Trendwatch Overcoming 5G Component Challenges eBook_CN.pdf
https://www.idtechex.com/en/research-report/low-loss-materials-for-5g-2021-2031/778
5G 应用材料
材料要求
—
—
—
—
—
—
—
—
—
下一步
https://www.avient.com/sites/default/files/2025-05/AVNT Q1 2025 Webcast Slides_w_non-GAAP.pdf
All Rights Reserved
2025
Playbook in current environment
1.
Executing flawlessly and continue advancing our strategy while
prioritizing investments and resources for our growth vectors
1.
2.
3.
4.
5.
6.
All Rights Reserved
2025
Color, Additives & Inks
E N D M A R K E T S R E G I O N S
34%
21%
15%
11%
9%
8%
Packaging
Telecom 1%Energy 1%
Transportation
Industrial
Consumer
34%
37%
20%
9%
US & Canada
Latin America
Asia
Europe, Middle East
and Africa
Healthcare
Building &
Construction
15Copyright © .
https://www.avient.com/sites/default/files/2022-04/Avient Acquisition of Dyneema and Q1 2022 Results_0.pdf
Avient acquired the Clariant Color business on July 1, 2020 (the “Acquisition Date”).
Morgan
• New Senior Secured Term Loan B and new Senior
Unsecured Notes
• Potential proceeds from sale of Distribution business
modeled to pay off 5.25% senior notes due 2023 and
Term Loan
• Acquisition aligned with Avient’s track record of
disciplined capital allocation policy
• Existing dividend policy maintained, focus on
deleveraging in the near term
(1)
(1) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution,
including repayment of senior notes due 2023 and Term Loan
Cash and Cash Equivalents 595$
Senior Secured Term Loan due 2026 605$
New Senior Secured Term Loan B 500
Total Senior Secured Debt 1,105$
Senior Unsecured Notes due 2025 650$
New Senior Unsecured Notes 740
Total Senior Unsecured Debt 1,390$
Total Debt 2,495$
Net Debt 1,900$
2022 Pro forma Adjusted EBITDA 660$
Net Debt / Adjusted EBITDA 2.9x
Pro Forma Capitalization
(2022 estimates, all figures in $M)
T WO - Y E A R L E V E R AG E G OA L
24
3.5x
2.7x
1.7x
2.9x
2.5x
2.2x
2019PF 2020PF 2022E 2022PF 2023E 2024E
Dyneema® AcquisitionClariant Color Acquisition
(1) Pro forma for the acquisition of the Clariant Color business
(2) Pro forma for the acquisition of Dyneema® and potential divestiture of
Distribution, including repayment of senior notes due 2023 and Term Loan
(1) (1) (2)
25
P RO F O R M A M O D E L I N G
2022E Pro Forma Pro Forma
($M) w/ Dyneema w/Sale
Revenue 5,100$ 415$ 5,515$ (1,775)$ 3,740$
Adjusted EBITDA 635 130 765 (105) 660
EBITDA % 12% 31% 14% 6% 18%
Pro Forma EPS (Adjusted) 3.50$ 0.00$ 3.50$ (0.56)$ 2.94$
Pro Forma EPS (excl. amortization) 3.96$ 0.35$ 4.31$ (0.56)$ 3.75$
Leverage (12/31/2022E)
Net Debt / Adjusted EBITDA 1.7x 3.5x 2.9x
Avient Dyneema Distribution® ®
OUR SPECIALTY JOURNEY
AC Q U I S I T I O N H I S TO RY
27
Commercial
Resources(1)
Operating Income
($ in millions)
Operating Margins
259
360
At Acquisition 2021
$40
$122
At Acquisition 2021
9%
21%
At Acquisition 2021
Established Acquisitions
(> 7 years)
+ 39% + 210% + 1200 bps
(1) Commercial Resources include associate headcount in R&D / Technical, Marketing and Sales
C L A R I A N T C O LO R AC Q U I S I T I O N
28
$133
$205
2019PF 2021
28
Clariant Color EBITDA Growth
Purchase Price Multiple
10.8x
7.0x
6.1x
2019PF 2021 2021 w/ Full
Synergies
• Acquisition of Clariant Color business significantly expanded
presence in healthcare, packaging and consumer end markets
• Strength of portfolio – double-digit annual EBITDA growth
since acquisition
• $54 million of synergies realized in 2021
• Acquisition completed on July 1, 2020 for $1.45 billion.
Purchase price multiple rapidly declining on strength of
business and synergy capture
(1)
(1)
(1) Financial information is pro forma to include a full year of Clariant Color acquisition
($ in millions)
11.9%
16.2%
2019PF 2021
EBITDA Margins
(1)
S P E C I A LT Y T R A N S F O R M AT I O N
7%
46%
66%
86%
100%
0%
20%
40%
60%
80%
100%
2005 2010 2015 2021 2022 PF
%
o
f A
dj
us
te
d
E
B
IT
D
A
(1
)
JVs Distribution Performance Products & Solutions Specialty
(1) Adjusted EBITDA is EBITDA excluding corporate costs and special items
(2) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution
(2)
29
12%
18%
16% 15% 15% 14% 14%
28% 28%
26%
25%
22% 21% 19%
16%
12%
9% 9%
A
vi
en
t T
od
ay
A
vi
en
t P
F
A
V
Y
P
P
G
K
W
R
FU
L
R
P
M C
E
A
LB
FM
C
A
S
H
E
C
L
E
M
N
H
X
L
H
U
N
S
C
L
B
N
R
U
N
V
R
Median: 21%Median: 15%
2 0 2 2 E B I T DA M A RG I N S V S .
https://www.avient.com/sites/default/files/resources/PDI_Healthcare_Brochure_2011_0.pdf
Polymer Diagnostics Inc.
33587 Walker Road
Avon Lake, Ohio 44012
United States
+1 800 438 2335
+1 440 930 1644 fax
Polymer Diagnostics Inc. is a contract laboratory with accreditation to ISO/IEC 17025 by the American
Association for Laboratory Accreditation (A2LA) for both chemical and mechanical capacities.
1 7 . 2
8 . 2 5 i n
8 . 5 i n
1 7
C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810
TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM
BL: 17.2500" x 11.9375"
FINAL: 8.2500" x 11.6875" and 8.500" x 11.000"
11
.6
8
7
5
in
2 5 i n
11
.9
3
7
5
in
8 . 2 5 i n
8 . 5 i n
11
in
i n
Asset No. 78810
Polymer Diagnostics Inc.
PDI has extensive experience with
the testing of medical devices and
materials including:
• Catheters
• Bio-implants
• Surgical diagnostic devices
• Medical tubing
• Other disposable medical devices
Issues often arise as a result of:
• Improper design or choice of material
• The environment of exposure
• Processing conditions
World-class people and capabilities
under one roof
• Failure Analysis/Prevention
• Qualifi cation Support
• Rheology
• Polymer Characterization
• Deformulation
• Physical Testing
• Litigation Support
• Characterization of polymers in pharmaceutical
delivery systems
• Phthalate and BPA testing
1 7 . 2
8 . 2 5 i n
8 . 5 i n
1 7
C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810
TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM
BL: 17.2500" x 11.9375"
FINAL: 8.2500" x 11.6875" and 8.500" x 11.000"
11
.6
8
7
5
in
2 5 i n
11
.9
3
7
5
in
8 . 2 5 i n
8 . 5 i n
11
in
i n
Asset No. 78810
Polymer Diagnostics Inc.
Polymer Diagnostics Inc.
33587 Walker Road
Avon Lake, Ohio 44012
United States
+1 800 438 2335
+1 440 930 1644 fax
Polymer Diagnostics Inc. is a contract laboratory with accreditation to ISO/IEC 17025 by the American
Association for Laboratory Accreditation (A2LA) for both chemical and mechanical capacities.
1 7 . 2
8 . 2 5 i n
8 . 5 i n
1 7
C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810
TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM
BL: 17.2500" x 11.9375"
FINAL: 8.2500" x 11.6875" and 8.500" x 11.000"
11
.6
8
7
5
in
2 5 i n
11
.9
3
7
5
in
8 . 2 5 i n
8 . 5 i n
11
in
i n
Asset No. 78810